The Lyon-based company Inova buys an online university-industry linking platform
France-based cloud solution Inova has acquired Sheffield and London-based IN-PART, a digital matchmaking platform dedicated to university-industry collaboration. This recent move will solidify Inova’s position as a leader in digitizing the biopharma partnership space. The acquisition is taking place thanks to its €60 million investment from global private equity firm Carlyle. The Lyon-based company had previously acquired the European biotechnology information media Labiotech,
By creating a stronger and more connected research ecosystem, this acquisition will ensure that academic breakthroughs will have an even greater impact on society. While IN-PART will continue to service and expand its platforms for all research sectors, by partnering with Inova, the company will gain access to Inova’s software infrastructure, as well as its industry-leading teams. market in terms of products and marketing. Inova customers will benefit from access to IN-PART search and discovery platforms, as well as best practices in matchmaking technology.
Gilles Toulemonde, Founder and CEO of Inova, said: “There is a growing consensus in the world of biopharmaceutical partnerships that academia is the next game changer. However, our customers often report how difficult it is to navigate the in-depth science produced by academic groups. IN-PART has built an impressive digital solution to meet this exact challenge and by acquiring them, we are now shaking up our mission and including academia in the world of next generation partnerships. Together, we help untapped science reach market through smart partnership. »
“This will give us access to many more resources and expertise for IN-PART to accelerate its growth and realize its vision of connecting the university-industry ecosystem, in all the fields and research sectors we work with. “, Patrick Speedie, Co-said the founder and director of IN-PART.
Robin Knight, co-founder and director of IN-PART added: “Bringing our companies together, as well as the exchange of expertise and technology between our teams, will allow us to accelerate the pace at which we help make emerge the next generation. treatments and technologies.
Inova supports more than 160 global clients, including many of the world’s largest pharmaceutical companies, while IN-PART develops curated digital solutions that drive research impact by simplifying the initial connection between academic and industrial teams in all sectors. Its matchmaking platform, Connect, is used by more than 250 universities and research institutes to find new commercialization partners in more than 6,000 companies.